scholarly journals Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data

BMJ ◽  
2015 ◽  
pp. h4937
Keyword(s):  
Systematic Review ◽  
Controlled Trial ◽  
Meta Analysis ◽  
Trial Data ◽  
Safety And Efficacy

scholarly journals Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data

BMJ ◽  
2015 ◽  
pp. h4451 ◽  
Author(s):  
Oliver J Ziff ◽  
Deirdre A Lane ◽  
Monica Samra ◽  
Michael Griffith ◽  
Paulus Kirchhof ◽  
...  
Keyword(s):  
Systematic Review ◽  
Controlled Trial ◽  
Meta Analysis ◽  
Trial Data ◽  
Safety And Efficacy

scholarly journals Safety and efficacy of lumen-apposing metal stents versus plastic stents to treat walled-off pancreatic necrosis: systematic review and meta-analysis

2020 ◽  
Vol 08 (11) ◽  
pp. E1639-E1653
Author(s):  
Vinay Chandrasekhara ◽  
Marc Barthet ◽  
Jacques Devière ◽  
Fateh Bazerbachi ◽  
Sundeep Lakhtakia ◽  
...  
Keyword(s):  
Systematic Review ◽  
Pancreatic Necrosis ◽  
Controlled Trial ◽  
Meta Analysis ◽  
Stent Migration ◽  
Plastic Stents ◽  
Metal Stents ◽  
Endoscopic Drainage ◽  
Stent Occlusion ◽  
Safety And Efficacy

Abstract Background and study aims Lumen-apposing metal stents (LAMS) are increasingly used for drainage of walled-off pancreatic necrosis (WON). Recent studies suggested greater adverse event (AE) rates with LAMS for WON. We conducted a systematic review and meta-analysis to compare the safety and efficacy of LAMS with double-pigtail plastic stents (DPPS) for endoscopic drainage of WON. The primary aim was to evaluate stent-related AEs. Methods In October 2019, we searched the Ovid (Embase, MEDLINE, Cochrane) and Scopus databases for studies assessing a specific LAMS or DPPS for WON drainage conducted under EUS guidance. Safety outcomes were AE rates of bleeding, stent migration, perforation, and stent occlusion. Efficacy outcomes were WON resolution and number of procedures needed to achieve resolution. A subanalysis including non-EUS-guided cases was performed. Results Thirty studies including one randomized controlled trial (total 1,524 patients) were analyzed. LAMS were associated with similar bleeding (2.5 % vs. 4.6 %, P = 0.39) and perforation risk (0.5 % vs. 1.1 %, P = 0.35) compared to DPPS. WON resolution (87.4 % vs. 87.5 %, P = 0.99), number of procedures to achieve resolution (2.09 vs. 1.88, P = 0.72), stent migration (5.9 % vs. 6.8 %, P = 0.79), and stent occlusion (3.8 % vs. 5.2 %, P = 0.78) were similar for both groups. Inclusion of non-EUS-guided cases led to significantly higher DPPS bleeding and perforation rates. Conclusions LAMS and DPPS were associated with similar rates of AEs and WON resolution when limiting analysis to EUS-guided cases. Higher bleeding rates were seen in historical studies of DPPS without EUS guidance. Additional high-quality studies of WON treatment using consistent outcome definitions are needed.

scholarly journals Safety and efficacy of intra-arterial fibrinolytics as adjunct to mechanical thrombectomy: a systematic review and meta-analysis of observational data

2021 ◽  
pp. neurintsurg-2020-016680
Author(s):  
Johannes Kaesmacher ◽  
Thomas Raphael Meinel ◽  
Christoph Kurmann ◽  
Osama O Zaidat ◽  
Alicia C Castonguay ◽  
...  
Keyword(s):  
Systematic Review ◽  
Observational Data ◽  
Mechanical Thrombectomy ◽  
Controlled Trial ◽  
Meta Analysis ◽  
Random Effect ◽  
Effect Estimate ◽  
Safety And Efficacy ◽  
Increased Risk ◽  
Secondary Endpoints

BackgroundAchieving the best possible reperfusion is a key determinant of clinical outcome after mechanical thrombectomy (MT). However, data on the safety and efficacy of intra-arterial (IA) fibrinolytics as an adjunct to MT with the intention to improve reperfusion are sparse.MethodsWe performed a PROSPERO-registered (CRD42020149124) systematic review and meta-analysis accessing MEDLINE, PubMed, and Embase from January 1, 2000 to January 1, 2020. A random-effect estimate (Mantel-Haenszel) was computed and summary OR with 95% CI were used as a measure of added IA fibrinolytics versus control on the risk of symptomatic intracranial hemorrhage (sICH) and secondary endpoints (modified Rankin Scale ≤2, mortality at 90 days).ResultsThe search identified six observational cohort studies and three observational datasets of MT randomized-controlled trial data reporting on IA fibrinolytics with MT as compared with MT alone, including 2797 patients (405 with additional IA fibrinolytics (100 urokinase (uPA), 305 tissue plasminogen activator (tPA)) and 2392 patients without IA fibrinolytics). Of 405 MT patients treated with additional IA fibrinolytics, 209 (51.6%) received prior intravenous tPA. We did not observe an increased risk of sICH after administration of IA fibrinolytics as adjunct to MT (OR 1.06, 95% CI 0.64 to 1.76), nor excess mortality (0.81, 95% CI 0.60 to 1.08). Although the mode of reporting was heterogeneous, some studies observed improved reperfusion after IA fibrinolytics.ConclusionThe quality of evidence regarding peri-interventional administration of IA fibrinolytics in MT is low and limited to observational data. In highly selected patients, no increase in sICH was observed, but there is large uncertainty.

Safety and efficacy of UV application for superficial infections in humans: A systematic review and meta-analysis

2021 ◽  
Author(s):  
Sanjay Marasini ◽  
Alexis Ceecee Zhang ◽  
Simon J. Dean ◽  
Simon Swift ◽  
Jennifer P. Craig
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document